drugset / Trial / NCT01699464
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
RandomizedParallel-groupTriple-blindTreatment
Summary
A double-masked, parallel study of AR-12286 Ophthalmic Solution 0.5%, or 0.7% (q.d., PM) or timolol maleate Ophthalmic Solution, 0.5% (b.i.d.), O.U. for 3 months.
Timeline
- Start
- 2012-10
- Primary completion
- 2013-04
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Timolol | Other / unclassified | 0.5 % | Other |
| Subject | VEROSUDIL | Small molecule | 0.5 % | Other |
| Subject | VEROSUDIL | Small molecule | 0.7 % | Other |